NASDAQ:ZYNE - Zynerba Pharmaceuticals News Headlines

$10.80
-1.07 (-9.01 %)
(As of 07/19/2019 04:00 PM ET)
Today's Range
$10.62
Now: $10.80
$12.04
50-Day Range
$10.65
MA: $13.18
$15.57
52-Week Range
$2.75
Now: $10.80
$16.47
Volume1.82 million shs
Average Volume1.91 million shs
Market Capitalization$227.61 million
P/E RatioN/A
Dividend YieldN/A
Beta4.86

Headlines

Zynerba Pharmaceuticals (NASDAQ ZYNE) News Headlines

Source:
DateHeadline
Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) Sees Large Increase in Short InterestZynerba Pharmaceuticals Inc (NASDAQ:ZYNE) Sees Large Increase in Short Interest
www.americanbankingnews.com - July 13 at 2:56 AM
Heres Why Zynerba Pharmaceuticals Stock Soared 356% in the First Half of the YearHere's Why Zynerba Pharmaceuticals Stock Soared 356% in the First Half of the Year
finance.yahoo.com - July 12 at 6:50 PM
Here's Why Zynerba Pharmaceuticals Stock Soared 356% in the First Half of the YearHere's Why Zynerba Pharmaceuticals Stock Soared 356% in the First Half of the Year
finance.yahoo.com - July 12 at 6:50 PM
Is Zynerba Pharmaceuticalss (NASDAQ:ZYNE) 102% Share Price Increase Well Justified?Is Zynerba Pharmaceuticals's (NASDAQ:ZYNE) 102% Share Price Increase Well Justified?
finance.yahoo.com - July 2 at 8:30 AM
Is Zynerba Pharmaceuticals's (NASDAQ:ZYNE) 102% Share Price Increase Well Justified?Is Zynerba Pharmaceuticals's (NASDAQ:ZYNE) 102% Share Price Increase Well Justified?
finance.yahoo.com - July 2 at 8:30 AM
Zynerba Gets Another Boost with Addition to Russell IndexZynerba Gets Another Boost with Addition to Russell Index
finance.yahoo.com - July 1 at 6:44 PM
Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) Receives Average Rating of "Buy" from AnalystsZynerba Pharmaceuticals Inc (NASDAQ:ZYNE) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - June 29 at 9:07 AM
Canaccord Genuity Analysts Give Zynerba Pharmaceuticals (NASDAQ:ZYNE) a $18.00 Price TargetCanaccord Genuity Analysts Give Zynerba Pharmaceuticals (NASDAQ:ZYNE) a $18.00 Price Target
www.americanbankingnews.com - June 29 at 6:31 AM
Canaccord Genuity Bullish On Zynerba Ahead Of CBD Gel Trial DataCanaccord Genuity Bullish On Zynerba Ahead Of CBD Gel Trial Data
finance.yahoo.com - June 28 at 6:26 PM
Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) Sees Significant Increase in Short InterestZynerba Pharmaceuticals Inc (NASDAQ:ZYNE) Sees Significant Increase in Short Interest
www.americanbankingnews.com - June 28 at 5:10 AM
 Analysts Expect Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) Will Post Earnings of -$0.50 Per Share Analysts Expect Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) Will Post Earnings of -$0.50 Per Share
www.americanbankingnews.com - June 27 at 10:18 PM
Zynerba Pharmaceuticals (ZYNE) Outpaces Stock Market Gains: What You Should KnowZynerba Pharmaceuticals (ZYNE) Outpaces Stock Market Gains: What You Should Know
finance.yahoo.com - June 19 at 7:46 PM
Zynerbas Zygel Can Beat Epidiolex, But Investment Case Still DubiousZynerba's Zygel Can Beat Epidiolex, But Investment Case Still Dubious
seekingalpha.com - June 18 at 9:12 PM
Meet the Newest Treatment for Autism Using CannabidiolMeet the Newest Treatment for Autism Using Cannabidiol
247wallst.com - June 11 at 7:10 PM
Zynerba Advances Cannabidiol Treatment With New Patent WinZynerba Advances Cannabidiol Treatment With New Patent Win
www.benzinga.com - June 11 at 7:10 PM
48 Stocks Moving In Tuesdays Mid-Day Session48 Stocks Moving In Tuesday's Mid-Day Session
feeds.benzinga.com - June 11 at 1:19 PM
Zynerba nabs new patent in U.S.; shares up 5% premarketZynerba nabs new patent in U.S.; shares up 5% premarket
seekingalpha.com - June 11 at 8:56 AM
Zynerba Pharmaceuticals Receives New U.S. Patent for Treatment of Autism Spectrum Disorder with CannabidiolZynerba Pharmaceuticals Receives New U.S. Patent for Treatment of Autism Spectrum Disorder with Cannabidiol
finance.yahoo.com - June 11 at 8:56 AM
Zynerba Pharmaceuticals: An Updated Investment ThesisZynerba Pharmaceuticals: An Updated Investment Thesis
seekingalpha.com - June 10 at 8:50 AM
Zynerba Pharmaceuticals: Analysts See More Upside after the RallyZynerba Pharmaceuticals: Analysts See More Upside after the Rally
finance.yahoo.com - June 7 at 3:42 PM
Here's What Last Week's FDA CBD Hearing Really Means for Cannabis StocksHere's What Last Week's FDA CBD Hearing Really Means for Cannabis Stocks
finance.yahoo.com - June 4 at 8:35 AM
Zynerba Initiates Phase II INSPIRE Trial Of ZygelZynerba Initiates Phase II INSPIRE Trial Of Zygel
finance.yahoo.com - May 31 at 6:46 PM
Zynerba Pharmaceuticals to Present at FDA’s Public Hearing on Scientific Data and Information aboutZynerba Pharmaceuticals to Present at FDA’s Public Hearing on Scientific Data and Information about
www.nasdaq.com - May 30 at 6:34 PM
Zynerba Pharmaceuticals to Present at FDA’s Public Hearing on Scientific Data and Information about Products Containing Cannabis or Cannabis-derived CompoundsZynerba Pharmaceuticals to Present at FDA’s Public Hearing on Scientific Data and Information about Products Containing Cannabis or Cannabis-derived Compounds
finance.yahoo.com - May 30 at 6:34 PM
Zynerba launches mid-stage study of Zygel in chromosome 22 disorderZynerba launches mid-stage study of Zygel in chromosome 22 disorder
seekingalpha.com - May 29 at 6:50 PM
Zynerba Pharmaceuticals Announces Initiation of Phase 2 Trial of Zygel™ in 22q11.2 Deletion SyndromeZynerba Pharmaceuticals Announces Initiation of Phase 2 Trial of Zygel™ in 22q11.2 Deletion Syndrome
finance.yahoo.com - May 29 at 8:32 AM
Zynerba Pharmaceuticals, Inc. (ZYNE) Shares March Higher, Can It Continue?Zynerba Pharmaceuticals, Inc. (ZYNE) Shares March Higher, Can It Continue?
finance.yahoo.com - May 21 at 9:09 AM
The Daily Biotech Pulse: Axovant Doses First Patient In Gene Therapy Trial, Agile Resubmits NDA, ADMA Prices OfferingThe Daily Biotech Pulse: Axovant Doses First Patient In Gene Therapy Trial, Agile Resubmits NDA, ADMA Prices Offering
feeds.benzinga.com - May 17 at 8:57 AM
Can We See Significant Insider Ownership On The Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Share Register?Can We See Significant Insider Ownership On The Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Share Register?
finance.yahoo.com - May 10 at 6:46 PM
Is Zynerba Pharmaceuticals (ZYNE) Outperforming Other Medical Stocks This Year?Is Zynerba Pharmaceuticals (ZYNE) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - May 8 at 7:29 PM
Zynerba Pharmaceuticals Reports First Quarter 2019 Financial Results and Operational HighlightsZynerba Pharmaceuticals Reports First Quarter 2019 Financial Results and Operational Highlights
www.nasdaq.com - May 8 at 8:32 AM
Zynerba Pharmaceuticals beats by $0.02Zynerba Pharmaceuticals beats by $0.02
seekingalpha.com - May 8 at 8:32 AM
Zynerba stock soars after getting 'fast track' designation for experimental cannibanoid therapyZynerba stock soars after getting 'fast track' designation for experimental cannibanoid therapy
finance.yahoo.com - May 6 at 7:32 PM
Why Zynerba Pharmaceuticals Stock Zoomed Higher TodayWhy Zynerba Pharmaceuticals Stock Zoomed Higher Today
finance.yahoo.com - May 6 at 7:32 PM
Zynerba +8% on receiving Fast Track Designation for ZygelZynerba +8% on receiving Fast Track Designation for Zygel
seekingalpha.com - May 6 at 8:30 AM
Zynerba Pharmaceuticals Receives Fast Track Designation for Zygel™ for the Treatment of Behavioral Symptoms Associated with Fragile X Syndrome (FXS)Zynerba Pharmaceuticals Receives Fast Track Designation for Zygel™ for the Treatment of Behavioral Symptoms Associated with Fragile X Syndrome (FXS)
finance.yahoo.com - May 6 at 8:30 AM
Why Zynerba Pharmaceuticals Stock Is Jumping TodayWhy Zynerba Pharmaceuticals Stock Is Jumping Today
finance.yahoo.com - April 30 at 6:45 PM
Zynerba Pharmaceuticals (ZYNE) Gains As Market Dips: What You Should KnowZynerba Pharmaceuticals (ZYNE) Gains As Market Dips: What You Should Know
finance.yahoo.com - April 24 at 6:29 PM
Is Zynerba Pharmaceuticals (ZYNE) Stock Outpacing Its Medical Peers This Year?Is Zynerba Pharmaceuticals (ZYNE) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - April 18 at 7:32 PM
Zynerba Pharmaceuticals (ZYNE) Dips More Than Broader Markets: What You Should KnowZynerba Pharmaceuticals (ZYNE) Dips More Than Broader Markets: What You Should Know
finance.yahoo.com - April 18 at 8:32 AM
Zynerba Rockets ForwardZynerba Rockets Forward
seekingalpha.com - April 8 at 12:23 AM
Zynerba adds to up move; shares ahead 16%Zynerba adds to up move; shares ahead 16%
seekingalpha.com - April 3 at 7:53 PM
Zynerba Pharmaceuticals to Present at the 2019 H.C. Wainwright Global Life Sciences ConferenceZynerba Pharmaceuticals to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
www.nasdaq.com - April 2 at 9:28 PM
Will Zynerba Pharmaceuticals Continue to Surge Higher?Will Zynerba Pharmaceuticals Continue to Surge Higher?
finance.yahoo.com - March 22 at 7:26 PM
SCYNEXIS Reports Full Year 2018 Financial Results and Provides Company UpdateSCYNEXIS Reports Full Year 2018 Financial Results and Provides Company Update
finance.yahoo.com - March 14 at 7:11 PM
CBD DrugsCBD Drugs
www.benzinga.com - March 12 at 8:48 AM
Zynerba Pharmaceuticals Adds Autism, DiGeorge Syndrome To PipelineZynerba Pharmaceuticals Adds Autism, DiGeorge Syndrome To Pipeline
www.benzinga.com - March 11 at 7:32 PM
Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2018 Financial Results and Operational HighlightsZynerba Pharmaceuticals Reports Fourth Quarter and Year End 2018 Financial Results and Operational Highlights
www.globenewswire.com - March 11 at 8:41 AM
Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2018 Financial Results and Operational HighlightsZynerba Pharmaceuticals Reports Fourth Quarter and Year End 2018 Financial Results and Operational Highlights
finance.yahoo.com - March 11 at 8:41 AM
Zynerba: 4Q Earnings SnapshotZynerba: 4Q Earnings Snapshot
finance.yahoo.com - March 11 at 8:41 AM
This page was last updated on 7/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel